The reactivity of a mother’s autoantibodies to specific fetal brain protein patterns may predict the child’s diagnosis with a type of autism known as MAR ASD. MAR ASD was present in around 20% of kids with autism in Arkansas and Philadelphia samples and was linked to more significant autistic traits.
Expressive language sampling yielded five language-related outcome measures that may be useful for treatment studies in intellectual disabilities, especially fragile X syndrome. The measures were generally valid and reliable across the range of ages, IQs and autism symptom severity of participants. According to the study, led by UC Davis researchers and funded by NIH, the measures are also functional in supporting treatments that can improve language, providing far reaching benefits for individuals with intellectual disabilities.